Overview

Atherosclerosis Monitoring and Atherogenicity Reduction Study

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to estimate the effect of two-year treatment with time-released garlic-based drug Allicor on the progression of carotid atherosclerosis in double-blinded placebo-controlled randomized clinical trial.
Phase:
Phase 3
Details
Lead Sponsor:
Institute for Atherosclerosis Research, Russia